
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1–CD44 Axis
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Saswati Karmakar, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1998-2013.e7
Open Access | Times Cited: 165
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Saswati Karmakar, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1998-2013.e7
Open Access | Times Cited: 165
Showing 26-50 of 165 citing articles:
Viscoelastic stiffening of gelatin hydrogels for dynamic culture of pancreatic cancer spheroids
Han Nguyen, Chien‐Chi Lin
Acta Biomaterialia (2024) Vol. 177, pp. 203-215
Closed Access | Times Cited: 12
Han Nguyen, Chien‐Chi Lin
Acta Biomaterialia (2024) Vol. 177, pp. 203-215
Closed Access | Times Cited: 12
Single-cell RNA sequencing of cervical exfoliated cells reveals potential biomarkers and cellular pathogenesis in cervical carcinogenesis
Bo Sheng, Shuya Pan, Miaomiao Ye, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 10
Bo Sheng, Shuya Pan, Miaomiao Ye, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 10
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Novel T cell exhaustion gene signature to predict prognosis and immunotherapy response in thyroid carcinoma from integrated RNA-sequencing analysis
Yang Li, Zhen Wang, Fangting Lu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Yang Li, Zhen Wang, Fangting Lu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Multiomic characterization, immunological and prognostic potential of SMAD3 in pan-cancer and validation in LIHC
Tao Zhou, Dan Dan Zhang, Jiejing jin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Tao Zhou, Dan Dan Zhang, Jiejing jin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing
Mei‐Ling Cheng, Guodong Liang, Zongyi Yin, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 9, pp. 5497-5512
Closed Access | Times Cited: 37
Mei‐Ling Cheng, Guodong Liang, Zongyi Yin, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 9, pp. 5497-5512
Closed Access | Times Cited: 37
New roles of tumor-derived exosomes in tumor microenvironment
Shiqian Chen, Jinzhe Sun, Huan Zhou, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 151-166
Open Access | Times Cited: 7
Shiqian Chen, Jinzhe Sun, Huan Zhou, et al.
Chinese Journal of Cancer Research (2024) Vol. 36, Iss. 2, pp. 151-166
Open Access | Times Cited: 7
Single‐cell transcriptome sequencing reveals SPP1 ‐CD44 ‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC
Fuzhong Liu, Junfeng Zhang, Xiaowei Gu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 7
Fuzhong Liu, Junfeng Zhang, Xiaowei Gu, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 13
Open Access | Times Cited: 7
LncRNA FOXD1-AS1 regulates pancreatic cancer stem cell properties and 5-FU resistance by regulating the miR-570-3p/SPP1 axis as a ceRNA
Liu Ouyang, Minmin Sun, Ping-sheng Zhou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Liu Ouyang, Minmin Sun, Ping-sheng Zhou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Osteopontin in Cancer: Mechanisms and Therapeutic Targets
Yoshinobu Kariya, Yukiko Kariya
International Journal of Translational Medicine (2022) Vol. 2, Iss. 3, pp. 419-447
Open Access | Times Cited: 25
Yoshinobu Kariya, Yukiko Kariya
International Journal of Translational Medicine (2022) Vol. 2, Iss. 3, pp. 419-447
Open Access | Times Cited: 25
Cytokines chattering in pancreatic ductal adenocarcinoma tumor microenvironment
Rakesh Bhatia, Namita Bhyravbhatla, Andrew Kisling, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 499-510
Open Access | Times Cited: 24
Rakesh Bhatia, Namita Bhyravbhatla, Andrew Kisling, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 499-510
Open Access | Times Cited: 24
Extracellular matrix remodeling facilitates obesity-associated cancer progression
Min Gyu Kim, Changhu Lee, Jiyoung Park
Trends in Cell Biology (2022) Vol. 32, Iss. 10, pp. 825-834
Closed Access | Times Cited: 24
Min Gyu Kim, Changhu Lee, Jiyoung Park
Trends in Cell Biology (2022) Vol. 32, Iss. 10, pp. 825-834
Closed Access | Times Cited: 24
Multi-Transcriptomic Analysis Reveals the Heterogeneity and Tumor-Promoting Role of SPP1/CD44-Mediated Intratumoral Crosstalk in Gastric Cancer
Wen Xie, Jia Cheng, Zhijun Hong, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 164-164
Open Access | Times Cited: 24
Wen Xie, Jia Cheng, Zhijun Hong, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 164-164
Open Access | Times Cited: 24
IRF8: Mechanism of Action and Health Implications
Hannah R. Moorman, Yazmin Reategui, Dakota B. Poschel, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2630-2630
Open Access | Times Cited: 23
Hannah R. Moorman, Yazmin Reategui, Dakota B. Poschel, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2630-2630
Open Access | Times Cited: 23
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance
Qiuzhi Gao, Yixiang Zhan, Li Sun, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2141-2154
Closed Access | Times Cited: 15
Qiuzhi Gao, Yixiang Zhan, Li Sun, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2141-2154
Closed Access | Times Cited: 15
Pancreatic cancer stemness: dynamic status in malignant progression
Yutong Zhao, Cheng Xue Qin, Bangbo Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 14
Yutong Zhao, Cheng Xue Qin, Bangbo Zhao, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 14
Engineered a dual-targeting HA-TPP/A nanoparticle for combination therapy against KRAS-TP53 co-mutation in gastrointestinal cancers
Yong Mei, Xiaohua Qin, Zhenyu Yang, et al.
Bioactive Materials (2023) Vol. 32, pp. 277-291
Open Access | Times Cited: 13
Yong Mei, Xiaohua Qin, Zhenyu Yang, et al.
Bioactive Materials (2023) Vol. 32, pp. 277-291
Open Access | Times Cited: 13
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Astha Lamichhane, Hossein Tavana
Cellular and Molecular Bioengineering (2024) Vol. 17, Iss. 2, pp. 107-119
Open Access | Times Cited: 5
Astha Lamichhane, Hossein Tavana
Cellular and Molecular Bioengineering (2024) Vol. 17, Iss. 2, pp. 107-119
Open Access | Times Cited: 5
The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 5
Meiyi Ge, Jian Luo, Yi Wu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 5
FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m6A modifications of multiple pro-angiogenic factors
Qili Liao, Hanhan Shi, Jie Yang, et al.
Cancer Letters (2024) Vol. 592, pp. 216911-216911
Closed Access | Times Cited: 5
Qili Liao, Hanhan Shi, Jie Yang, et al.
Cancer Letters (2024) Vol. 592, pp. 216911-216911
Closed Access | Times Cited: 5
FAP positive cancer‐associated fibroblasts promote tumor progression and radioresistance in esophageal squamous cell carcinoma by transferring exosomal lncRNA AFAP1‐AS1
Xilei Zhou, Yu‐Suo Tong, Changhua Yu, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 10, pp. 1922-1937
Open Access | Times Cited: 5
Xilei Zhou, Yu‐Suo Tong, Changhua Yu, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 10, pp. 1922-1937
Open Access | Times Cited: 5
Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy
Wenshe Sun, Shaowei Xie, Shi Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3919-3942
Open Access | Times Cited: 4
Wenshe Sun, Shaowei Xie, Shi Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3919-3942
Open Access | Times Cited: 4
Spatial transcriptomics reveals tumor-derived SPP1 induces fibroblast chemotaxis and activation in the hepatocellular carcinoma microenvironment
Wen Tong, Tianze Wang, Yi Bai, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Wen Tong, Tianze Wang, Yi Bai, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Macrophage heterogeneity and oncogenic mechanisms in lung adenocarcinoma: insights from scRNA-seq analysis and predictive modeling
Han Zhang, Jiaxing Dai, Qiuqiao Mu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Han Zhang, Jiaxing Dai, Qiuqiao Mu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Jifa Li, Xiaoqiong Bao, Wenwen Yu, et al.
The Kaohsiung Journal of Medical Sciences (2025)
Open Access